New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free
Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Friday, November 13, 2026

Back to the front page

From X

@convequity

Convequity on X

Marvell buying Lumentum is easier to understand strategically than financially. Four days after $MRVL announced its all-stock acquisition of $LITE, I understand why both sides want it. I remain unconvinced by the shareholder economics at the announced $115bn enterprise value. Smart bulls long $LITE after mid-2026 for its UHP CW story, but we don't. Lumentum's ultra-high-power laser advantage depends on the optical architecture customers choose. Moving the light source closer to the optical engine can reduce losses and change the power required. Today's component bottleneck may become less valuable as the system design changes. External lasers still offer cooling and replacement advantages. Broadcom $AVGO uses them too; its strength is coordinating switch silicon, optical engines and packaging. Huawei's Hi-ONE takes a different route with a built-in light source. Both reinforce the importance of controlling the broader design. That helps explain Marvell's motivation. In AI clusters, weaker networking can leave expensive accelerators idle. A cheaper networking component may never compensate for the lost compute. Buying Lumentum gives Marvell more control over the optical technology it needs to compete. But shareholders have to fund that integration. Marvell holders exchange roughly one-third of the combined company for Lumentum. Lumentum holders receive a fixed number of Marvell shares, leaving them exposed to Marvell's share price and the combined company's execution. We have always being negative on $MRVL vs. $AVGO. Always a tier 2 mgt in both vision and execution. The expected first-half-2028 close is a nightmare for a catch-up strategy. Both companies can keep developing products, but the benefits of combined ownership remain deferred. Broadcom and Huawei have time to advance their designs and deepen customer deployments. By closing, the competitive gap could be wider. I would assign no value to an NVIDIA $NVDA rescue. NVIDIA already has investments and partnerships with both companies. It can access their technology without acquiring the business; a takeover would still depend on price and regulatory clearance. The strategic rationale is understandable. The shareholder case needs customer wins and earnings that justify the ownership exchanged, integration costs and time lost. I remain skeptical.
@calvinblissett

Calvin Blissett on X

$CCLD: They can reach it in the public markets with continued execution imo as they show AI resilience and benefits as well as continued software development, tuck in acquisitions and integration of Medsphere without too much churn . They have before achieved those multiples in the public markets. That said I would love to be the one to take them private, I think anyone doing so gets a “platform” and a steal and want that to happen because I have so many opportunities I could easily redeploy the cash in names where I have just as high conviction.

Investor Letters

All letters

QXO Inc Earnings Update: Q3 2026

QXO's Q3 sales rose 79% to $4.9 billion after TopBuild and Kodiak acquisitions, while acquisition debt lifted interest expense to $163…

QXO $13B
SixSigmaCapital: Navigating the Financial Markets 2 clicks

IEH Corporation: Research Note

IEH Corporation posted Q2 revenue growth of 51% to $10.7 million and a record $56 million backlog, led by defense and medical demand.

IEHC $78M
Atrium Research - Equity Research 1 click

Qure Anniversary Update

UniQure’s Huntington’s disease BLA has a May 1, 2027 priority-review date, with an FDA advisory committee expected in late first quarter.

QURE $1.7B
Triple S Special Situations Investing 2 clicks

Big Short: Fidelity & Guaranty

F&G’s main insurer held $66.5 billion of assets against $1.38 billion of statutory capital, while private credit, reinsurance dependence…

FG $3.1B
Mispriced Assets 4 clicks

Publications we follow

Every publication on this site, hand-picked.

130 publications

Newsletters 110

YouTube 4

Blogs 15

Seeking Alpha 85 of 289

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

376 firms

Sectors

Ordered by how often our editor reaches for them.